The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 23, 2022

Filed:

Jan. 29, 2021
Applicant:

4d Molecular Therapeutics Inc., Emeryville, CA (US);

Inventors:

David H. Kirn, Emeryville, CA (US);

Melissa Kotterman, Emeryville, CA (US);

David Schaffer, Emeryville, CA (US);

Assignee:

4D Molecular Therapeutics Inc., Emeryville, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61K 9/00 (2006.01); C12N 15/85 (2006.01); A61P 27/02 (2006.01); C07K 14/005 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0016 (2013.01); A61K 9/0019 (2013.01); A61K 9/0048 (2013.01); A61K 48/0025 (2013.01); A61K 48/0058 (2013.01); A61K 48/0075 (2013.01); A61P 27/02 (2018.01); C07K 14/005 (2013.01); C12N 15/86 (2013.01); C07K 2319/00 (2013.01); C12N 2750/14122 (2013.01); C12N 2750/14143 (2013.01);
Abstract

Provided herein are variant adeno-associated virus (AAV) capsid proteins having one or more modifications in amino acid sequence relative to a parental AAV capsid protein, which, when present in an AAV virion, confer increased infectivity of one or more types of retinal cells as compared to the infectivity of the retinal cells by an AAV virion comprising the unmodified parental AAV capsid protein. Also provided are recombinant AAV virions and pharmaceutical compositions thereof comprising a variant AAV capsid protein as described herein, methods of making these rAAV capsid proteins and virions, and methods for using these rAAV capsid proteins and virions in research and in clinical practice, for example in, e.g., the delivery of nucleic acid sequences to one or more cells of the retina for the treatment of retinal disorders and diseases.


Find Patent Forward Citations

Loading…